Stereotactic Body Radiotherapy for the Treatment of Renal Tumors
The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growi...
Main Authors: | Michael Hanzly, Terrance Creighton, Michael Mix, Kevin Zeeck, Simon Fung-Kee-Fung, Anurag K. Singh, Thomas Schwaab |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-09-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442014000795 |
Similar Items
-
Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01) -
Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01) -
Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience
by: Laure Grelier, et al.
Published: (2021-06-01) -
Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01) -
Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial
by: Vivek Verma, et al.
Published: (2017-04-01)